https://www.mlo-online.com/management/news/55368572/something-exciting-is-coming-on-tuesdayMLO Onlineen2026-04-03T14:34:02.000ZSomething exciting is coming on Tuesday…https://www.mlo-online.com/diagnostics/news/55368570/cdc-test-directory-updatesMLO Onlineen2026-04-03T14:28:36.000ZCDC test directory updateshttps://www.mlo-online.com/disease/infectious-disease/news/55368568/cdc-update-shows-declining-respiratory-virus-activity-in-the-usMLO Onlineen2026-04-03T14:25:14.000ZCDC update shows declining respiratory virus activity in the U.S. https://www.mlo-online.com/molecular/news/55368565/thermo-fisher-launches-automated-gibco-cts-compleo-system-for-cell-therapy-manufacturingMLO Onlineen2026-04-03T14:23:03.000ZThermo Fisher launches automated Gibco CTS Compleo System for cell therapy manufacturinghttps://www.mlo-online.com/directory/equipment-services/specialty-products-services/virology-products-services/press-release/55368547/diasorin-diasorin-signs-strategic-distribution-agreement-with-mckesson-medical-surgical-to-expand-access-for-the-liaison-nes-molecular-point-of-care-platform-and-the-flu-a-b-rsv-covid-19-panel-in-nonacute-settings-across-the-united-statesMLO Onlineen2026-04-03T13:43:45.000ZDIASORIN SIGNS STRATEGIC DISTRIBUTION AGREEMENT WITH MCKESSON MEDICAL SURGICAL TO EXPAND ACCESS FOR THE LIAISON NES MOLECULAR POINT-OF-CARE PLATFORM AND THE FLU A/B, RSV & COVID-19 PANEL IN NON‑ACUTE SETTINGS ACROSS THE UNITED STATEShttps://www.mlo-online.com/directory/tests/molecular-diagnostics/nucleic-acid-amplification-products-detection-systems/press-release/55368540/diasorin-diasorin-submits-liaison-nes-group-a-strep-molecular-test-to-the-us-fda-for-510k-clearance-and-clia-waiverMLO Onlineen2026-04-03T13:07:51.000ZDIASORIN SUBMITS LIAISON NES GROUP A STREP MOLECULAR TEST TO THE U.S. FDA FOR 510(K) CLEARANCE AND CLIA WAIVERhttps://www.mlo-online.com/directory/equipment-services/specialty-products-services/virology-products-services/press-release/55368485/diasorin-diasorin-signs-exclusive-distribution-agreement-for-the-liaison-nes-molecular-point-of-care-platform-and-the-flu-a-b-rsv-covid-19-panelMLO Onlineen2026-04-03T13:07:04.000ZDIASORIN SIGNS EXCLUSIVE DISTRIBUTION AGREEMENT FOR THE LIAISON NES® MOLECULAR POINT-OF-CARE PLATFORM AND THE FLU A/B, RSV & COVID-19 PANELhttps://www.mlo-online.com/disease/news/55368308/connection-found-between-vitamin-d-and-tau-proteinMLO Onlineen2026-04-02T15:11:52.000ZConnection found between vitamin D and tau proteinhttps://www.mlo-online.com/disease/cancer/news/55368306/cap-updates-head-and-neck-cancer-reporting-protocols-for-2026MLO Onlineen2026-04-02T15:04:50.000ZCAP updates head and neck cancer reporting protocols for 2026https://www.mlo-online.com/molecular/dna-rna/news/55368303/primerdesign-and-origin-sciences-to-enhance-novel-rectal-mucosal-extractionMLO Onlineen2026-04-02T14:59:16.000ZPrimerdesign and Origin Sciences to enhance novel rectal mucosal extraction https://www.mlo-online.com/information-technology/news/55368293/elpida-unveils-regulatory-compliance-platform-for-healthcareMLO Onlineen2026-04-02T14:51:29.000ZElpida unveils regulatory compliance platform for healthcare